Loading viewer...
investor_presentation
Format: PDF investor_presentation
GSK presented strategic ambitions for 2021-2026, targeting over 5% sales CAGR and 10% adjusted operating profit CAGR. The company prioritizes Vaccines and Specialty Medicines, optimizing its General Medicines portfolio while maintaining a progressive dividend policy and strengthening its balance sheet to support growth investments.
investor_presentation
40 Pages
The Toro Company
Mettler-Toledo International Investor Presentation — February 2021
investor_presentationinvestor_presentation
10 Pages
Mettler-Toledo International Inc.